These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19958826)

  • 21. Metabolic Activation of Pesticide Isoprocarb Mediated by CYP3A4 and the Possible Correlation with Its Cytotoxicity.
    Guan C; Zhao G; Sun C; Zhang M; Liu S; Jiang Z; Li W; Peng Y; Zheng J
    J Agric Food Chem; 2023 Feb; 71(5):2390-2398. PubMed ID: 36706223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular toxicity of clopidogrel: mechanisms and risk factors.
    Zahno A; Bouitbir J; Maseneni S; Lindinger PW; Brecht K; Krähenbühl S
    Free Radic Biol Med; 2013 Dec; 65():208-216. PubMed ID: 23770199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct protection against acetaminophen hepatotoxicity by propylthiouracil. In vivo and in vitro studies in rats and mice.
    Yamada T; Ludwig S; Kuhlenkamp J; Kaplowitz N
    J Clin Invest; 1981 Mar; 67(3):688-95. PubMed ID: 7204554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of MDCKII cell monolayer with metabolic activity by CYP3A4 transduced with recombinant adenovirus.
    Kataoka M; Terashima Y; Mizuno K; Masaoka Y; Sakuma S; Yokoi T; Yamashita S
    Drug Metab Pharmacokinet; 2013; 28(2):125-31. PubMed ID: 22892444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
    Kasahara M; Suzuki H; Komiya I
    Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.
    Slitt AM; Dominick PK; Roberts JC; Cohen SD
    Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):487-94. PubMed ID: 15910414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an optimized cytotoxicity assay system for CYP3A4-mediated metabolic activation via modified piggyBac transposition.
    Huang L; Zou S; Deng J; Dai T; Jiang J; Jia Y; Dai R; Xie S
    Toxicol In Vitro; 2016 Apr; 32():132-7. PubMed ID: 26706816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced gamma-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity.
    Das GC; Bacsi A; Shrivastav M; Hazra TK; Boldogh I
    Mol Carcinog; 2006 Sep; 45(9):635-47. PubMed ID: 16491484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites.
    Tang W; Stearns RA; Bandiera SM; Zhang Y; Raab C; Braun MP; Dean DC; Pang J; Leung KH; Doss GA; Strauss JR; Kwei GY; Rushmore TH; Chiu SH; Baillie TA
    Drug Metab Dispos; 1999 Mar; 27(3):365-72. PubMed ID: 10064567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.
    Tipnis SR; Blake DG; Shepherd AG; McLellan LI
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):559-66. PubMed ID: 9895302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells.
    Lorico A; Bratbak D; Meyer J; Kunke D; Krauss S; Plott WE; Solodushko V; Baum C; Fodstad O; Rappa G
    Hum Gene Ther; 2005 Jun; 16(6):711-24. PubMed ID: 15960602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism.
    Valdés-Arzate A; Luna A; Bucio L; Licona C; Clemens DL; Souza V; Hernandez E; Kershenobich D; Gutiérrez-Ruiz MC; Gómez-Quiroz LE
    Free Radic Biol Med; 2009 Aug; 47(4):424-30. PubMed ID: 19463946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorometric assessment of acetaminophen-induced toxicity in rat hepatocyte spheroids seeded on micro-space cell culture plates.
    Sanoh S; Santoh M; Takagi M; Kanayama T; Sugihara K; Kotake Y; Ejiri Y; Horie T; Kitamura S; Ohta S
    Toxicol In Vitro; 2014 Sep; 28(6):1176-82. PubMed ID: 24878114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidation of the relationship between evodiamine-induced liver injury and CYP3A4-mediated metabolic activation by UPLC-MS/MS analysis.
    Peng T; Rao J; Zhang T; Wang Y; Li N; Gao Q; Feng X; Song Z; Wang K; Qiu F
    Anal Bioanal Chem; 2023 Sep; 415(23):5619-5635. PubMed ID: 37433953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of glutathione synthesis and conjugation by 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dihydroxymethamphetamine (HHMA) in human and rat liver cells, including the protective role of some antioxidants.
    Antolino-Lobo I; Meulenbelt J; Molendijk J; Nijmeijer SM; Scherpenisse P; van den Berg M; van Duursen MB
    Toxicology; 2011 Nov; 289(2-3):175-84. PubMed ID: 21871945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro determination of the CYP 3A4 activity in rat hepatic microsomes by liquid-phase extraction and HPLC-photodiode array detection.
    Baati T; Horcajada P; Gref R; Couvreur P; Serre C
    J Pharmacol Toxicol Methods; 2012 Jul; 66(1):29-34. PubMed ID: 22643301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of deltamethrin on gene expression of some antioxidase, gamma glutamylcysteine synthetase and NFE2 related factor 2 (Nrf2) in brain tissue].
    Li HY; Shi N; Dai ZH; Zhong YF; Wu SY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 May; 24(5):273-7. PubMed ID: 16737586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance.
    Jia Y; Zhang W; Liu H; Peng L; Yang Z; Lou J
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):377-85. PubMed ID: 21833590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins.
    Usui T; Mise M; Hashizume T; Yabuki M; Komuro S
    Drug Metab Dispos; 2009 Dec; 37(12):2383-92. PubMed ID: 19720731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.